Literature DB >> 9183701

Neurokinin receptor mRNA localization in human midbrain dopamine neurons.

C J Whitty1, M A Paul, M J Bannon.   

Abstract

The structurally related neurokinin peptides, substance P and neurokinin A, are found in abundance within the substantia nigra of a variety of mammalian species. Although it has been established recently that the neurokinin-3 (NK3) receptor is the predominant neurokinin receptor found in rat substantia nigra and adjacent midbrain nuclei, the nature of the neurokinin receptor expressed in human midbrain has not been elucidated. In the present study, neurokinin receptor messenger RNA (mRNA) content within rat and human midbrain were directly compared by using quantitative in situ hybridization histochemistry. In contrast to the high abundance of NK3 receptor mRNA within dopamine (DA) cells of the rat midbrain, neurokinin-1 (NK1), but not NK3, receptor mRNA was localized to human midbrain DA cells. Within the human midbrain, the abundance of NK1 receptor mRNA differed significantly among the distinct DA cell-containing nuclei, with the highest level of expression seen in several subdivisions of the substantia nigra. Thus different neurokinin receptor subtypes apparently mediate the effects of substance P and neurokinin A on human versus rat DA neurons.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9183701

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  8 in total

1.  Visualization and quantification of neurokinin-1 (NK1) receptors in the human brain.

Authors:  Jarmo Hietala; Mikko J Nyman; Olli Eskola; Aki Laakso; Tove Grönroos; Vesa Oikonen; Jörgen Bergman; Merja Haaparanta; Sarita Forsback; Päivi Marjamäki; Pertti Lehikoinen; Michael Goldberg; Donald Burns; Terence Hamill; Wai-Si Eng; Alexandre Coimbra; Richard Hargreaves; Olof Solin
Journal:  Mol Imaging Biol       Date:  2005 Jul-Aug       Impact factor: 3.488

Review 2.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

3.  Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers.

Authors:  Michael J Bannon; Barb Pruetz; Amy B Manning-Bog; Christopher J Whitty; Sharon K Michelhaugh; Paola Sacchetti; James G Granneman; Deborah C Mash; Carl J Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

Review 4.  The mammalian tachykinin ligand-receptor system: an emerging target for central neurological disorders.

Authors:  Nick Pantaleo; Wayne Chadwick; Sung-Soo Park; Liyun Wang; Yu Zhou; Bronwen Martin; Stuart Maudsley
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-11       Impact factor: 4.388

5.  Cognitive performance in neurokinin 3 receptor knockout mice.

Authors:  R E Nordquist; M Delenclos; T M Ballard; H Savignac; M Pauly-Evers; L Ozmen; W Spooren
Journal:  Psychopharmacology (Berl)       Date:  2008-03-20       Impact factor: 4.530

6.  Of mice and men: bridging the translational disconnect in CNS drug discovery.

Authors:  Hugo Geerts
Journal:  CNS Drugs       Date:  2009-11       Impact factor: 5.749

Review 7.  The pharmacology of neurokinin receptors in addiction: prospects for therapy.

Authors:  Alexander J Sandweiss; Todd W Vanderah
Journal:  Subst Abuse Rehabil       Date:  2015-09-07

8.  A molecular profile of cocaine abuse includes the differential expression of genes that regulate transcription, chromatin, and dopamine cell phenotype.

Authors:  Michael J Bannon; Magen M Johnson; Sharon K Michelhaugh; Zachary J Hartley; Steven D Halter; James A David; Gregory Kapatos; Carl J Schmidt
Journal:  Neuropsychopharmacology       Date:  2014-03-19       Impact factor: 7.853

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.